Table 4 The association between hypertensive retinopathy and the UACR by subgroup^a

Sex

0.498

 Male

1070

8.3 (6.1,13.2)

ref

2.54(-0.16,5.25)

4.3(0.77,7.82)

8.17(1.15,15.19)

 Female

1893

11.8 (8.3,18.7)

ref

0.97(-0.9,2.83)

1.97(-0.57,4.52)

3.48(-1.45,8.41)

Age, years

0.107

  < 65

1769

10 (7.1,15.7)

ref

0.95(-0.97,2.86)

2.78(0.26,5.29)

1.56(-3.58,6.7)

  ≥ 65

1178

11.4 (7.5,19.3)

ref

2.27(-0.28,4.82)

2.24(-1.33,5.81)

10.5(3.94,17.06)

BMI, kg/m2

0.220

  < 24

1042

10.3 (7.1,16.6)

ref

-0.62(-3.17,1.93)

2.19(-1.31,5.69)

4.3(-2.53,11.12)

  ≥ 24, < 28

1178

10.3 (7.2,16.7)

ref

1.97(-0.42,4.35)

3.5(0.29,6.72)

6.15(-0.44,12.75)

  ≥ 28

728

11.2 (7.6,18.3)

ref

3.15(-0.11,6.41)

1.48(-2.72,5.67)

6.54(-1.4,14.49)

Treatment group

0.380

 Enalapril

1255

10.3 (7.1,16.5)

ref

0.37(-1.69,2.43)

1.85(-0.91,4.61)

7.55(1.53,13.58)

 Enalapril + folic acid

1222

10 (7,15.7)

ref

2.72(0.31,5.13)

4(0.76,7.25)

5.06(-0.81,10.94)

SBP, mmHg

0.402

  < 140

1686

9.5 (6.8,14.9)

ref

1.2(-0.67,3.07)

2.97(0.39,5.56)

1.74(-3.76,7.24)

  ≥ 140

1246

11.9 (8.1,20.2)

ref

2.05(-0.55,4.64)

2.47(-0.88,5.83)

8.49(2.51,14.48)

TG, mmol/L

0.023

  < 1.7

1722

10.1 (7,15.9)

ref

0.21(-1.64,2.06)

1.19(-1.34,3.73)

7.59(2.8,12.37)

  ≥ 1.7

1201

11.1 (7.7,18.6)

ref

3.17(0.53,5.81)

4.7(1.25,8.15)

0.13(-7.04,7.31)

TCHO, mmol/L

0.353

  < 5.2

1259

10.2 (7.2,16.5)

ref

2.06(-0.1,4.22)

2.7(-0.34,5.74)

8.94(3.18,14.7)

  ≥ 5.2

1642

10.7 (7.2,17.5)

ref

0.92(-1.24,3.07)

2.64(-0.16,5.45)

1.76(-3.86,7.38)

FBG, mmol/L

0.251

  < 7.0

2393

10 (7.1,15.7)

ref

0.89(-0.68,2.46)

2.42(0.28,4.55)

3.87(-0.76,8.51)

  ≥ 7.0

508

13.8 (8.4,23.4)

ref

4.22(-0.76,9.2)

3.17(-3.13,9.46)

9.2(0.04,18.37)

HCY, μmol/L

0.882

  < 10

686

10.5 (7.7,17.9)

ref

0.65(-2.4,3.7)

0.8(-3.37,4.96)

9.38(0.31,18.44)

  ≥ 10, < 15

1554

10.4 (7.2,16.8)

ref

1.55(-0.54,3.64)

2.44(-0.43,5.31)

3.67(-1.52,8.86)

  ≥ 15

678

10.3 (7.1,16.8)

ref

1.75(-1.67,5.17)

3.77(-0.57,8.12)

5.4(-4.26,15.06)

Hyperuricemia

0.432

 No

2303

10.5 (7.2,17.2)

ref

1.72(0.04,3.41)

2.13(-0.17,4.43)

5.61(1.03,10.2)

 Yes

624

10.3 (7.1,16.7)

ref

0.82(-2.87,4.5)

4.05(-0.6,8.71)

3(-5.59,11.58)

Smoking status

0.014

 Never

2094

11.3 (7.8,18.3)

ref

0.67(-1.09,2.43)

1.77(-0.62,4.16)

2.46(-2.12,7.03)

 Former

284

8.9 (6.5,14.1)

ref

3.54(-2.08,9.17)

4.79(-2.65,12.24)

-5.3(-20.25,9.65)

 Current

569

8.7 (6.2,14.1)

ref

2.5(-1.22,6.23)

4.64(-0.13,9.42)

18.73(8.47,29)

Alcohol consumption

0.447

 Never

2089

11.1 (7.8,18.1)

ref

1.05(-0.68,2.77)

2.14(-0.2,4.47)

4.11(-0.38,8.6)

 Former

168

9 (6.7,19.5)

ref

4.56(-4.69,13.81)

3.29(-8.53,15.11)

11.04(-17.93,40.01)

 Current

575

9 (6.2,14.5)

ref

1.43(-2.05,4.9)

4.24(-0.29,8.77)

5.93(-3.35,15.2)